Cybin inc. reports first quarter financial results and recent business highlights

Toronto--(business wire)--cybin inc. (neo:cybn) (nyse american:cybn) (“cybin” or the “company”), a biopharmaceutical company focused on progressing “psychedelics to therapeuticstm”, today reported unaudited financial results for its first quarter ended june 30, 2022 and recent business highlights. “looking back at the last 12 months, we have made positive progress toward our goal of advancing psychedelics to therapeutics. in that time, we have moved from the lab to the clinic where we now have
CYBN Ratings Summary
CYBN Quant Ranking